Mol. Cells 2012; 33(2): 203-210
Published online January 26, 2012
https://doi.org/10.1007/s10059-012-2271-8
© The Korean Society for Molecular and Cellular Biology
Correspondence to : *Correspondence: kwonhj@yonsei.ac.kr
1,2-Dibromoethane and glycidol are well known genotoxic carcinogens, which have been widely used in industry. To identify a specific biomarker for these car-cinogens in cells, the cellular proteome of L5178Y mouse lymphoma cells treated with these compounds was ana-lyzed by 2-dimen-sional gel electrophoresis (2-DE) and MALDI-TOF mass spectrometry (MS). Of 50 protein spots showing a greater than 1.5-fold increase or decrease in intensity compared to control cells on a 2-D gel, we fo-cused on the candidate biomarker moesin. Western analysis using monoclonal rabbit anti-moesin confirmed the identity of the protein and its increased level of expression upon exposure to the carcinogenic compounds. Moesin expression also increased in cells treated with six additional genotoxic carcinogens, verifying that moesin could serve as a biomarker to monitor phenotypic change upon exposure to genotoxic carcinogens in L5178Y mouse lymphoma cells.
Keywords biomarker, genotoxic carcinogen, moesin, toxicoproteomics
Mol. Cells 2012; 33(2): 203-210
Published online February 29, 2012 https://doi.org/10.1007/s10059-012-2271-8
Copyright © The Korean Society for Molecular and Cellular Biology.
Yoen Jung Lee1,2, In-Kwon Choi1,2, Yhun Yhong Sheen3, Sue Nie Park4, and Ho Jeong Kwon1,2,*
1Department of Biotechnology, Yonsei University, Seoul 120-749, Korea, 2Translational Research Center for Protein Function Control, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Korea, 3College of Pharmacy, Ewha Womans University, Seoul 120-750, Korea, 4Hazardous Substances Analysis Division at Seoul Regional FDA, Korea Food and Drug Administration, Seoul 158-050, Korea
Correspondence to:*Correspondence: kwonhj@yonsei.ac.kr
1,2-Dibromoethane and glycidol are well known genotoxic carcinogens, which have been widely used in industry. To identify a specific biomarker for these car-cinogens in cells, the cellular proteome of L5178Y mouse lymphoma cells treated with these compounds was ana-lyzed by 2-dimen-sional gel electrophoresis (2-DE) and MALDI-TOF mass spectrometry (MS). Of 50 protein spots showing a greater than 1.5-fold increase or decrease in intensity compared to control cells on a 2-D gel, we fo-cused on the candidate biomarker moesin. Western analysis using monoclonal rabbit anti-moesin confirmed the identity of the protein and its increased level of expression upon exposure to the carcinogenic compounds. Moesin expression also increased in cells treated with six additional genotoxic carcinogens, verifying that moesin could serve as a biomarker to monitor phenotypic change upon exposure to genotoxic carcinogens in L5178Y mouse lymphoma cells.
Keywords: biomarker, genotoxic carcinogen, moesin, toxicoproteomics
Yoen Jung Lee, In-Kwon Choi, Yhun Yhong Sheen, Sue Nie Park, and Ho Jeong Kwon*
Mol. Cells 2012; 33(3): 309-316 https://doi.org/10.1007/s10059-012-2280-7Byeonggeun Kang, Byunghee Kang, Tae-Young Roh, Rho Hyun Seong, and Won Kim
Mol. Cells 2022; 45(5): 343-352 https://doi.org/10.14348/molcells.2022.0001Jieun Lee, Youngju Kim, Seonghee Jin, Heeseung Yoo, Sumin Jeong, Euna Jeong, and Sukjoon Yoon
Mol. Cells 2021; 44(11): 843-850 https://doi.org/10.14348/molcells.2021.0169